Guardian Pharmacy Services (GRDN) Receivables (2023 - 2026)

Guardian Pharmacy Services has reported Receivables for 4 years, with the latest figure at $111.7 million in Q1 2026.

• Quarterly Receivables rose 14.68% year-over-year to $111.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.7 million (up 14.68% YoY) and the FY2025 annual result came in at $101.6 million, up 4.59% from the prior year.
• Receivables grew to $111.7 million in Q1 2026 per GRDN's latest filing, from $101.6 million in the prior quarter.
• Over five years, Receivables peaked at $111.7 million in Q1 2026 and troughed at $77.3 million in Q4 2023.
• A 4-year average of $97.0 million and a median of $97.3 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2024 and 2025: Receivables increased 25.74% in 2024, then grew 4.59% in 2025.
• Over 4 years, Receivables stood at $77.3 million in 2023, then climbed by 25.74% to $97.2 million in 2024, then grew by 4.59% to $101.6 million in 2025, then rose by 9.93% to $111.7 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $111.7 million, $101.6 million, and $106.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.